Over the past decade, “Digital Transformation” has become one of the most widely used—and often misused—terms in business. It has graced keynote speeches, investor pitch decks, consulting proposals, and corporate mission statements. And while it’s often touted as the cure-all for operational inefficiency, competitive stagnation, and regulatory complexity, the term itself has lost much of
Tag Archives: regulatory compliance
For young pharma companies, the focus is typically on research, securing funding, and pushing products through the development pipeline. However, the need for a more structured, automated Quality Management System (QMS) becomes critical as operations grow. At that point, moving from manual processes to an automated QMS is not just a “nice to have”—it is
It is just a guess, but over the last 25 years, I have probably helped about 100 companies transition from paper-based systems to automated systems for managing documents, quality processes, and training activities. One thing I have learned is that for some companies, the transition is fast and relatively painless, and for others, it can
Almost every argument about why investments in automated Quality Management Systems (QMS) are justified centers on compliance. And that makes perfect sense because failure to meet the requirements of regulatory authorities would be catastrophic for any pharma company. But for just a moment—stick with me here—imagine a world without regulatory authorities, no FDA or EMA,
The pharmaceutical industry in Brazil continues to experience rapid growth, driven by demand for innovative therapies and increasing healthcare access. While that growth presents new opportunities for pharmaceutical companies, navigating the evolving regulatory environment poses significant challenges for companies seeking to bring new products to market. At the heart of the process lies ANVISA (Agência
The life sciences industry in MENA is in the midst of a transformation. A combination of new technologies, changes in the market, and rapidly evolving regulatory requirements are driving significant changes in how drug companies in MENA operate. And it is clear that this period of rapid change will continue into 2024. Here is a
Quality and manufacturing managers know that a method for documenting and reviewing accurate batch records is the single most important element in a pharmaceutical manufacturing and quality process. That’s because, without accurate batch records, even a well-designed quality system will be vulnerable to audit findings and warning letters. After all, nobody wants to receive a
Document management is an essential function for pharmaceutical companies. It allows them to efficiently store, organize, and retrieve important documents related to drug development, clinical trials, manufacturing, distribution, and other business critical information. Failure to effectively manage these documents can result in serious consequences such as fines, delays in product launch, and even legal action.